Wunderlich Capital Managemnt lessened its position in Colgate-Palmolive (NYSE:CL) by 0.9% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 18,844 shares of the company’s stock after selling 169 shares during the quarter. Wunderlich Capital Managemnt’s holdings in Colgate-Palmolive were worth $1,397,000 as of its most recent filing with the SEC.
Several other large investors have also recently modified their holdings of the stock. Transamerica Financial Advisors Inc. lifted its position in Colgate-Palmolive by 0.3% in the 1st quarter. Transamerica Financial Advisors Inc. now owns 25,183 shares of the company’s stock worth $1,844,000 after buying an additional 67 shares in the last quarter. Ronald Blue & Co. LLC lifted its position in Colgate-Palmolive by 1.1% in the 1st quarter. Ronald Blue & Co. LLC now owns 3,501 shares of the company’s stock worth $256,000 after buying an additional 37 shares in the last quarter. USS Investment Management Ltd lifted its position in Colgate-Palmolive by 1.6% in the 1st quarter. USS Investment Management Ltd now owns 683,600 shares of the company’s stock worth $50,036,000 after buying an additional 10,600 shares in the last quarter. Stifel Financial Corp lifted its position in Colgate-Palmolive by 0.8% in the 1st quarter. Stifel Financial Corp now owns 303,934 shares of the company’s stock worth $22,250,000 after buying an additional 2,360 shares in the last quarter. Finally, ARS Investment Partners LLC lifted its position in Colgate-Palmolive by 0.5% in the 1st quarter. ARS Investment Partners LLC now owns 35,531 shares of the company’s stock worth $2,601,000 after buying an additional 175 shares in the last quarter. Institutional investors and hedge funds own 72.96% of the company’s stock.
In related news, insider Victoria L. Dolan sold 9,000 shares of the firm’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total value of $660,690.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CMO Mukul Deoras sold 7,500 shares of the firm’s stock in a transaction on Friday, November 10th. The shares were sold at an average price of $73.28, for a total transaction of $549,600.00. Following the completion of the transaction, the chief marketing officer now owns 45,217 shares in the company, valued at $3,313,501.76. The disclosure for this sale can be found here. Insiders sold a total of 173,673 shares of company stock worth $12,629,293 over the last quarter. 1.02% of the stock is currently owned by company insiders.
Colgate-Palmolive (CL) opened at $73.32 on Friday. The firm has a market cap of $64,277.30, a price-to-earnings ratio of 25.50, a PEG ratio of 3.35 and a beta of 0.81. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. Colgate-Palmolive has a twelve month low of $63.43 and a twelve month high of $77.27.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter last year, the firm earned $0.73 EPS. Colgate-Palmolive’s revenue for the quarter was up 2.8% on a year-over-year basis. sell-side analysts forecast that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Monday, October 23rd were paid a $0.40 dividend. The ex-dividend date was Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a yield of 2.18%. Colgate-Palmolive’s payout ratio is presently 61.78%.
A number of research firms have issued reports on CL. Jefferies Group reiterated a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Societe Generale downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price for the company. in a research report on Wednesday, November 29th. They noted that the move was a valuation call. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Finally, Macquarie initiated coverage on shares of Colgate-Palmolive in a report on Thursday, September 14th. They set a “neutral” rating and a $76.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and four have issued a buy rating to the company’s stock. Colgate-Palmolive presently has a consensus rating of “Hold” and an average price target of $76.04.
TRADEMARK VIOLATION WARNING: “Colgate-Palmolive (CL) Shares Sold by Wunderlich Capital Managemnt” was first posted by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://transcriptdaily.com/2017/12/09/colgate-palmolive-cl-shares-sold-by-wunderlich-capital-managemnt.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.